Cloudy or particulate solutions should not be used
The Sun 2021 study used the APP/PS1 transgenic mouse model of Alzheimers disease, with intragastric administration of Dihexa at 1.44 mg/kg or 2.88 mg/kg once daily for three months (six to nine months of age in the APP/PS1 cohort)
Professional Monitoring: Regular follow-up visits may be necessary to monitor the patients response to therapy and adjust dosages if needed
IGF-1 LR3 is engineered to do the same thing, but for a much longer period of time and without being captured by the proteins that normally limit IGF-1 activity
AOD9604 has been studied in preclinical and early clinical settings, and it received GRAS (Generally Recognized as Safe) designation from the US FDA for use as a food ingredient
BPC-157 demonstrates dual action: it heals the intestinal lining and reduces gut permeability while simultaneously modulating serotonin, dopamine, GABA, and other neurotransmitter systems in the brain